Financials Renata PLC

Equities

RENATA

BD0457RENAT6

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
759.9 BDT -3.00% Intraday chart for Renata PLC -5.06% -37.61%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 96,514 90,910 128,602 144,239 139,689 87,158 - -
Enterprise Value (EV) 1 94,544 87,797 126,534 150,822 139,689 87,158 87,158 87,158
P/E ratio 23.4 x 20.6 x 23.1 x 26.4 x 59.7 x 21.4 x 16.6 x 11.9 x
Yield 0.92% 1.39% 1.1% 1.11% - 0.7% 0.91% 2.53%
Capitalization / Revenue 4.23 x 3.68 x 4.29 x 4.64 x - 2.36 x 2.06 x 1.8 x
EV / Revenue 4.23 x 3.68 x 4.29 x 4.64 x - 2.36 x 2.06 x 1.8 x
EV / EBITDA 15.8 x 13.3 x 16.3 x 18.7 x - 11.6 x 9.31 x 7.57 x
EV / FCF 40.5 x 43.2 x 69 x -20.4 x - -64 x 32.6 x 16.9 x
FCF Yield 2.47% 2.32% 1.45% -4.9% - -1.56% 3.06% 5.9%
Price to Book 4.72 x 3.8 x 5 x 4.58 x - 2.57 x 2.26 x 1.93 x
Nbr of stocks (in thousands) 114,696 114,696 114,696 114,696 114,696 114,696 - -
Reference price 2 841.5 792.6 1,121 1,258 1,218 759.9 759.9 759.9
Announcement Date 11/28/19 11/29/20 10/23/21 11/27/22 11/14/23 - - -
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 22,809 24,675 29,971 31,071 - 36,958 42,308 48,326
EBITDA 1 6,091 6,814 7,892 7,696 - 7,509 9,362 11,509
EBIT 1 5,290 5,859 6,863 6,527 - 6,281 7,994 10,050
Operating Margin 23.19% 23.74% 22.9% 21.01% - 16.99% 18.89% 20.8%
Earnings before Tax (EBT) 1 5,154 5,878 6,777 6,123 - 5,088 6,568 9,171
Net income 1 3,756 4,012 5,062 5,111 2,339 4,070 5,254 7,337
Net margin 16.46% 16.26% 16.89% 16.45% - 11.01% 12.42% 15.18%
EPS 2 36.02 38.48 48.54 47.68 20.40 35.50 45.80 64.00
Free Cash Flow 1 2,382 2,106 1,864 -7,061 - -1,362 2,671 5,146
FCF margin 10.44% 8.54% 6.22% -22.73% - -3.69% 6.31% 10.65%
FCF Conversion (EBITDA) 39.11% 30.91% 23.62% - - - 28.53% 44.71%
FCF Conversion (Net income) 63.43% 52.5% 36.82% - - - 50.84% 70.14%
Dividend per Share 2 7.724 11.05 12.32 14.00 - 5.300 6.900 19.20
Announcement Date 11/28/19 11/29/20 10/23/21 11/27/22 11/14/23 - - -
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - 6,583 - - - -
Net Cash position 1,970 3,113 2,068 - - - - -
Leverage (Debt/EBITDA) - - - 0.8554 x - - - -
Free Cash Flow 1 2,382 2,106 1,864 -7,061 - -1,362 2,671 5,146
ROE (net income / shareholders' equity) 22% 19.9% 21.3% 18.5% - 12% 13.6% 16.2%
ROA (Net income/ Total Assets) 16.3% 14.8% - 13.3% - 7.7% 8.9% 11.9%
Assets 1 23,012 27,031 - 38,394 - 52,857 59,034 61,655
Book Value Per Share 2 178.0 209.0 224.0 274.0 - 296.0 337.0 394.0
Cash Flow per Share - - - - - - - -
Capex 1,849 2,493 4,423 10,070 - - - -
Capex / Sales 8.11% 10.1% 14.76% 32.41% - - - -
Announcement Date 11/28/19 11/29/20 10/23/21 11/27/22 11/14/23 - - -
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
759.9 BDT
Average target price
1,109 BDT
Spread / Average Target
+45.94%
Consensus

Annual profits - Rate of surprise